标题
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
作者
关键词
-
出版物
EUROPEAN RESPIRATORY JOURNAL
Volume -, Issue -, Pages 1900953
出版商
European Respiratory Society (ERS)
发表日期
2020-05-26
DOI
10.1183/13993003.00953-2019
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
- (2019) Alice Guazzelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
- (2019) Arnaud Scherpereel et al. LANCET ONCOLOGY
- Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial
- (2019) Maria J Disselhorst et al. Lancet Respiratory Medicine
- Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial
- (2019) Neil Bayman et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Immune Checkpoint Inhibitors in Mesothelioma
- (2019) Patrick M. Forde et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND—A Double-Blind, Randomized, Phase II Study
- (2019) Dean A. Fennell et al. JOURNAL OF CLINICAL ONCOLOGY
- Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial
- (2019) Giorgio V Scagliotti et al. Lancet Respiratory Medicine
- EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.
- (2019) Andrew G. Nicholson et al. Journal of Thoracic Oncology
- National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study
- (2018) Sahar A. Saddoughi et al. ANNALS OF THORACIC SURGERY
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
- (2018) Aliya Noor Husain et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Carcinogenicity of multi-walled carbon nanotubes: challenging issue on hazard assessment
- (2018) Shoji Fukushima et al. JOURNAL OF OCCUPATIONAL HEALTH
- Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1)
- (2018) Samuel G. Armato et al. Journal of Thoracic Oncology
- Novel therapies for malignant pleural mesothelioma
- (2018) Arnaud Scherpereel et al. LANCET ONCOLOGY
- Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis
- (2018) Ioannis Psallidas et al. LANCET ONCOLOGY
- Current efforts in research of pleural mesothelioma – an analysis of the clinicaltrials.gov registry
- (2018) Krisztian Süveg et al. LUNG CANCER
- Update of the systematic review of palliative radiation therapy fractionation for bone metastases
- (2018) Shayna E. Rich et al. RADIOTHERAPY AND ONCOLOGY
- British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
- (2018) Ian Woolhouse et al. THORAX
- Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study
- (2018) Luana Calabrò et al. Lancet Respiratory Medicine
- ERS/EACTS statement on the management of malignant pleural effusions
- (2018) Anna C. Bibby et al. EUROPEAN RESPIRATORY JOURNAL
- Investigating Unilateral Pleural Effusions: The role of cytology
- (2018) DT Arnold et al. EUROPEAN RESPIRATORY JOURNAL
- Inherited predisposition to malignant mesothelioma (MM) due to mutations in DNA repair genes.
- (2018) Raffit Hassan et al. JOURNAL OF CLINICAL ONCOLOGY
- DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma—First results.
- (2018) Anna K. Nowak et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
- (2018) Vasiliki Panou et al. JOURNAL OF CLINICAL ONCOLOGY
- State of the Art review - Surgery in Malignant Pleural Mesothelioma
- (2018) Raphael Bueno et al. Journal of Thoracic Oncology
- Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes
- (2018) Andrew Churg et al. LUNG CANCER
- “It sort of hit me like a baseball bat between the eyes”: a qualitative study of the psychosocial experiences of mesothelioma patients and carers
- (2018) Shenouda Girgis et al. SUPPORTIVE CARE IN CANCER
- Real-life treatment practice for malignant pleural mesothelioma in Belgium
- (2018) Michael Rosskamp et al. LUNG CANCER
- Time trends and spatial patterns in the mesothelioma incidence in Slovenia, 1961–2014
- (2017) Vesna Zadnik et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma†
- (2017) David B Nelson et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center
- (2017) Alberto M. Marchevsky et al. HUMAN PATHOLOGY
- A 30-year mortality and respiratory morbidity study of refractory ceramic fiber workers
- (2017) Grace LeMasters et al. INHALATION TOXICOLOGY
- Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014
- (2017) Ali H. Mokdad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis
- (2017) David B. Nelson et al. JOURNAL OF CLINICAL ONCOLOGY
- Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A Meta-Epidemiologic Study of Trials With Results Posted at ClinicalTrials.gov
- (2017) Aidan Tan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
- (2017) Emma Beddowes et al. JOURNAL OF CLINICAL ONCOLOGY
- Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial
- (2017) Federica Grosso et al. JOURNAL OF CLINICAL ONCOLOGY
- The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma
- (2017) Bibhusal Thapa et al. Journal of Thoracic Oncology
- Epidemiology of Environmental Exposure and Malignant Mesothelioma
- (2017) Bian Liu et al. Journal of Thoracic Oncology
- Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
- (2017) Michele Maio et al. LANCET ONCOLOGY
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
- (2017) Evan W Alley et al. LANCET ONCOLOGY
- BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
- (2017) Angela Bononi et al. NATURE
- Estimation of the global burden of mesothelioma deaths from incomplete national mortality data
- (2017) Chimed-Ochir Odgerel et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Ambient Asbestos Fiber Concentrations and Long-Term Trends in Pleural Mesothelioma Incidence between Urban and Rural Areas in the United States (1973-2012)
- (2017) Meghan E. Glynn et al. RISK ANALYSIS
- Data Quality in Rare Cancers Registration: The Report of the RARECARE Data Quality Study
- (2017) Annalisa Trama et al. TUMORI
- Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
- (2017) Dongxu Pei et al. Oncotarget
- Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1–Deficient Malignant Pleural Mesothelioma
- (2017) Peter W. Szlosarek et al. JAMA Oncology
- Effect of Radiotherapy on Painful Bone Metastases
- (2017) Rachel McDonald et al. JAMA Oncology
- Data Quality in Rare Cancers Registration: The Report of the RARECARE Data Quality Study
- (2017) Annalisa Trama et al. TUMORI JOURNAL
- Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033
- (2017) Kyeong Min Kwak et al. PLoS One
- Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens
- (2016) Harry C. Hwang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma
- (2016) Valerie W. Rusch et al. ANNALS OF THORACIC SURGERY
- Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations
- (2016) Brandon S. Sheffield et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Incidence of malignant mesothelioma in Germany 2009–2013
- (2016) Martin Lehnert et al. CANCER CAUSES & CONTROL
- CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma
- (2016) M. Betti et al. CANCER LETTERS
- Multiwalled carbon nanotubes intratracheally instilled into the rat lung induce development of pleural malignant mesothelioma and lung tumors
- (2016) Masumi Suzui et al. CANCER SCIENCE
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients
- (2016) A. Napolitano et al. CLINICAL CANCER RESEARCH
- Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma
- (2016) Diana Y. Kircheva et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study
- (2016) Jianguang Ji et al. EUROPEAN RESPIRATORY JOURNAL
- Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma
- (2016) Andreas Rimner et al. JOURNAL OF CLINICAL ONCOLOGY
- BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study
- (2016) Luisella Righi et al. Journal of Thoracic Oncology
- A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207
- (2016) Paul Wheatley-Price et al. Journal of Thoracic Oncology
- A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis
- (2016) Fraser J.H. Brims et al. Journal of Thoracic Oncology
- A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes
- (2016) Wieneke A. Buikhuisen et al. Journal of Thoracic Oncology
- Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma
- (2016) Andrea Billé et al. Journal of Thoracic Oncology
- The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation
- (2016) Harvey Pass et al. Journal of Thoracic Oncology
- The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
- (2016) David Rice et al. Journal of Thoracic Oncology
- The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
- (2016) Valerie W. Rusch et al. Journal of Thoracic Oncology
- The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
- (2016) Anna K. Nowak et al. Journal of Thoracic Oncology
- The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification
- (2016) Francoise Galateau-Salle et al. Journal of Thoracic Oncology
- Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles
- (2016) Pascal Andujar et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
- Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
- (2016) Gérard Zalcman et al. LANCET
- Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
- (2016) Amelia O Clive et al. LANCET ONCOLOGY
- Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure
- (2016) Melike Demir et al. LUNG
- Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma
- (2016) Katharina Martini et al. LUNG CANCER
- 195 A feasibility study comparing (extended) pleurectomy decortication versus no pleurectomy decortication in the multimodality management of patients with malignant pleural mesothelioma: the MARS 2 study
- (2016) E. Lim LUNG CANCER
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
- (2016) Raphael Bueno et al. NATURE GENETICS
- Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982–2009
- (2016) Matthew J Soeberg et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Response to: ‘Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment’ by Ferranteet al
- (2016) Gary M Marsh et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers
- (2016) Ilaria Bononi et al. Oncotarget
- Malignant mesothelioma incidence by nation-wide cancer registry: a population-based study
- (2016) Kristinn Tomasson et al. Journal of Occupational Medicine and Toxicology
- Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database
- (2016) Andrea Farioli et al. Cancer Medicine
- ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
- (2016) D. James Morré et al. Clinical Proteomics
- Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival
- (2016) Jennifer Beebe-Dimmer et al. Clinical Epidemiology
- Incidence of malignant mesothelioma of the pleura in Québec and Canada from 1984 to 2007, and projections from 2008 to 2032
- (2015) Alfreda Krupoves et al. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) P. Baas et al. ANNALS OF ONCOLOGY
- Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009
- (2015) Matthew J. Soeberg et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
- Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry
- (2015) Marisa Corfiati et al. BMC CANCER
- The next mesothelioma wave: Mortality trends and forecast to 2030 in Brazil
- (2015) Eduardo Algranti et al. Cancer Epidemiology
- Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction
- (2015) Mitchell Cheung et al. CANCER LETTERS
- Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study
- (2015) Jiegou Xu et al. CANCER SCIENCE
- Gene–asbestos interaction in malignant pleural mesothelioma susceptibility
- (2015) Sara Tunesi et al. CARCINOGENESIS
- Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
- (2015) Alan Serrels et al. CELL
- Impact of an asbestos cement factory on mesothelioma incidence: Global assessment of effects of occupational, familial, and environmental exposure
- (2015) Carolina Mensi et al. ENVIRONMENT INTERNATIONAL
- Are pleural plaques an appropriate endpoint for risk analyses?
- (2015) L. Daniel Maxim et al. INHALATION TOXICOLOGY
- Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors
- (2015) Emilio Minatel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM)
- (2015) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial
- (2015) Nicholas MacLeod et al. Journal of Thoracic Oncology
- A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma
- (2015) Isabelle Opitz et al. Journal of Thoracic Oncology
- Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
- (2015) Lee M Krug et al. LANCET ONCOLOGY
- Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
- (2015) Rolf A Stahel et al. LANCET ONCOLOGY
- Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma
- (2015) Lory Santarelli et al. LUNG CANCER
- Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England
- (2015) R.A. Damhuis et al. LUNG CANCER
- Second line therapy in malignant pleural mesothelioma: A systematic review
- (2015) Wieneke A. Buikhuisen et al. LUNG CANCER
- Loss of BAP1 function leads to EZH2-dependent transformation
- (2015) Lindsay M LaFave et al. NATURE MEDICINE
- Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment
- (2015) Daniela Ferrante et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- A case–control study of mesothelioma in Minnesota iron ore (taconite) miners
- (2015) Christine S Lambert et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues
- (2015) Alessandro Marinaccio et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden
- (2015) Bengt Järvholm et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- NLRP1 and NLRP3 polymorphisms in mesothelioma patients and asbestos exposed individuals a population-based autopsy study from North East Italy
- (2015) Violetta Borelli et al. Infectious Agents and Cancer
- Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study
- (2015) Luana Calabrò et al. Lancet Respiratory Medicine
- High-risk mesothelioma relation to meteorological and geological condition and distance from naturally occurring asbestos
- (2015) Abdurrahman Abakay et al. Environmental Health and Preventive Medicine
- Extrapleural Pneumonectomy in the Treatment of Epithelioid Malignant Pleural Mesothelioma
- (2014) David J. Sugarbaker et al. ANNALS OF SURGERY
- Asbestos: use, bans and disease burden in Europe
- (2014) Takashi Kameda et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Regional variations in German mesothelioma mortality rates: 2000–2010
- (2014) Sara J. Schonfeld et al. CANCER CAUSES & CONTROL
- Familial malignant mesothelioma: A population-based study in Central Italy (1980–2012)
- (2014) Valeria Ascoli et al. Cancer Epidemiology
- Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994–2009
- (2014) Cormac J. Jennings et al. Cancer Epidemiology
- Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival
- (2014) Francine Baumann et al. CARCINOGENESIS
- Physician-Based Ultrasound-Guided Biopsy for Diagnosing Pleural Disease
- (2014) Robert J. Hallifax et al. CHEST
- Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: A systematic review and meta-analysis
- (2014) Zhi-De Hu et al. CLINICA CHIMICA ACTA
- Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma
- (2014) R. Hassan et al. CLINICAL CANCER RESEARCH
- Asbestos-related occupational cancers compensated under the Spanish National Insurance System, 1978–2011
- (2014) Montserrat García-Gómez et al. INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
- Asbestos in Belgium: an underestimated health risk. The evolution of mesothelioma mortality rates (1969–2009)
- (2014) Laura Van den Borre et al. INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
- Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
- (2014) Harvey I. Pass et al. Journal of Thoracic Oncology
- A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy: The “SMART” Approach for Resectable Malignant Pleural Mesothelioma
- (2014) B.C. John Cho et al. Journal of Thoracic Oncology
- Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients
- (2014) Pietro Bovolato et al. Journal of Thoracic Oncology
- Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial
- (2014) Robert C Rintoul et al. LANCET
- Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes
- (2014) Yann Grosse et al. LANCET ONCOLOGY
- Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma
- (2014) L.M. Krug et al. LUNG CANCER
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in Central Mexico: Table 1
- (2014) M Adrián Ortega-Guerrero et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Mortality experience among Minnesota taconite mining industry workers
- (2014) Elizabeth M Allen et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Is Soluble Mesothelin-Related Protein an Upfront Predictive Marker of Pleural Mesothelioma A Prospective Study on Italian Workers Exposed to Asbestos
- (2014) Rosa Filiberti et al. ONCOLOGY
- Genetic Variants Associated with Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study
- (2014) Giuseppe Matullo et al. PLoS One
- Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
- (2014) Jenette Creaney et al. THORAX
- Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma
- (2014) A Lacourt et al. THORAX
- Pleural Mesothelioma and Occupational Coexposure to Asbestos, Mineral Wool, and Silica
- (2013) Aude Lacourt et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020
- (2013) Gonzalo López-Abente et al. BMC CANCER
- Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
- (2013) G L Ceresoli et al. BRITISH JOURNAL OF CANCER
- High Risk of Malignant Mesothelioma and Pleural Plaques in Subjects Born Close to Ophiolites
- (2013) Mehmet Bayram et al. CHEST
- Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens
- (2013) E. E. Habib et al. Clinical & Translational Oncology
- Environmental occurrence, origin, physical and geochemical properties, and carcinogenic potential of erionite near San Miguel de Allende, Mexico
- (2013) M. Adrián Ortega-Guerrero et al. ENVIRONMENTAL GEOCHEMISTRY AND HEALTH
- Geologic occurrences of erionite in the United States: an emerging national public health concern for respiratory disease
- (2013) Bradley S. Van Gosen et al. ENVIRONMENTAL GEOCHEMISTRY AND HEALTH
- The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province, Turkey
- (2013) Serdar Berk et al. ENVIRONMENTAL GEOCHEMISTRY AND HEALTH
- Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)
- (2013) Mary E.R. O’Brien et al. EUROPEAN JOURNAL OF CANCER
- Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers
- (2013) Michael K. Felten et al. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
- Lung cancer and mesothelioma risk assessment for a population environmentally exposed to asbestos
- (2013) Marie-Hélène Bourgault et al. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
- Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008
- (2013) S Jane Henley et al. INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
- Pleural Plaques and the Risk of Pleural Mesothelioma
- (2013) Jean-Claude Pairon et al. JNCI-Journal of the National Cancer Institute
- Phase 2 Study of Sorafenib in Malignant Mesothelioma Previously Treated with Platinum-Containing Chemotherapy
- (2013) Sophie Papa et al. Journal of Thoracic Oncology
- Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
- (2013) Luana Calabrò et al. LANCET ONCOLOGY
- Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study
- (2013) Wieneke A Buikhuisen et al. LANCET ONCOLOGY
- Serum Biomarkers in Patients with Mesothelioma and Pleural Plaques and Healthy Subjects Exposed to Naturally Occurring Asbestos
- (2013) Mehmet Bayram et al. LUNG
- A genome-wide association study for malignant mesothelioma risk
- (2013) Gemma Cadby et al. LUNG CANCER
- A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
- (2013) Anna K. Nowak et al. LUNG CANCER
- Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma
- (2013) Pascal Andujar et al. MUTAGENESIS
- Pleural mesothelioma in relation to meteorological conditions and residential distance from an industrial source of asbestos: Table 1
- (2013) Josep Tarrés et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma
- (2013) Mitchell Cheung et al. Cancer Genetics
- Domestic Asbestos Exposure: A Review of Epidemiologic and Exposure Data
- (2013) Emily Goswami et al. International Journal of Environmental Research and Public Health
- Malignant mesothelioma incidence among talc miners and millers in New York State
- (2012) Murray M. Finkelstein AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- A decade of malignant mesothelioma surveillance in Korea
- (2012) Soon-Hee Jung et al. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- All-cause mortality and cancer incidence among adults exposed to blue asbestos during childhood
- (2012) Alison Reid et al. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- Compensation of pleural mesothelioma in France: Data from the French National Mesothelioma Surveillance Programme
- (2012) Soizick Chamming's et al. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial
- (2012) Ó Arrieta et al. BRITISH JOURNAL OF CANCER
- Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma
- (2012) S. Bolukbas et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma
- (2012) A. Nakas et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure†
- (2012) Stefan B. Watzka et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later
- (2012) A. Gogali et al. EUROPEAN RESPIRATORY JOURNAL
- Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma: Table 1–
- (2012) Ioannis Pantazopoulos et al. EUROPEAN RESPIRATORY JOURNAL
- Are airborne refractory ceramic fibers similar to asbestos in their carcinogenicity?
- (2012) Alexander M. Walker et al. INHALATION TOXICOLOGY
- Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
- (2012) Nicholas de Klerk et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer morbidity of residents living near an oil refinery plant in North-West Italy
- (2012) Christian Salerno et al. INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH
- Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis
- (2012) Kevin Hollevoet et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
- (2012) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Impacts of land use on spatial distribution of mortality rates of cancers caused by naturally occurring asbestos
- (2012) Binggan Wei et al. Journal of Exposure Science and Environmental Epidemiology
- Mesothelioma Associated With Commercial Use of Vermiculite Containing Libby Amphibole
- (2012) Kari K. Dunning et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma
- (2012) Dean A. Fennell et al. Journal of Thoracic Oncology
- Pleural Fluid Cytological Yield and Visceral Pleural Invasion in Patients with Epithelioid Malignant Pleural Mesothelioma
- (2012) Valentina Pinelli et al. Journal of Thoracic Oncology
- Incidence and Survival of Malignant Pleural Mesothelioma in Norway: A Population-Based Study of 1686 Cases
- (2012) Åslaug Helland et al. Journal of Thoracic Oncology
- Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma
- (2012) Michaela B. Kirschner et al. Journal of Thoracic Oncology
- Phase II Study of Dasatinib in Patients with Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): A Brief Report
- (2012) Arkadiusz Z. Dudek et al. Journal of Thoracic Oncology
- Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
- (2012) Valerie W. Rusch et al. Journal of Thoracic Oncology
- A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma
- (2012) Jonathan E. Dowell et al. LUNG CANCER
- Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium
- (2012) Nicholas P. Campbell et al. LUNG CANCER
- Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
- (2012) Harvey I. Pass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
- (2012) Rachel M. Ostroff et al. PLoS One
- Industrial pollution and pleural cancer mortality in Spain
- (2012) Gonzalo López-Abente et al. SCIENCE OF THE TOTAL ENVIRONMENT
- NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
- (2012) Alessandra Pontillo et al. Infectious Agents and Cancer
- Surgical Management of Malignant Pleural Mesothelioma
- (2012) Jane Yanagawa et al. Thoracic Surgery Clinics
- Pleural mesothelioma mortality and asbestos exposure mapping in Italy
- (2011) Lucia Fazzo et al. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma
- (2011) Viljem Kovac et al. ANTI-CANCER DRUGS
- Soluble markers for diagnosis of malignant pleural mesothelioma
- (2011) Alfonso Cristaudo et al. Biomarkers in Medicine
- Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
- (2011) Vanya Delgermaa et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
- (2011) Alessandro Marinaccio et al. INTERNATIONAL JOURNAL OF CANCER
- Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group
- (2011) Scott A. Laurie et al. Journal of Thoracic Oncology
- Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509
- (2011) Linda L. Garland et al. Journal of Thoracic Oncology
- Serial Measurements of Mesothelioma Serum Biomarkers in Asbestos-Exposed Individuals: A Prospective Longitudinal Cohort Study
- (2011) Kevin Hollevoet et al. Journal of Thoracic Oncology
- Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group
- (2011) David Rice et al. Journal of Thoracic Oncology
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
- (2011) Tom Treasure et al. LANCET ONCOLOGY
- Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)
- (2011) Thierry Jahan et al. LUNG CANCER
- Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
- (2011) Nola J Olsen et al. MEDICAL JOURNAL OF AUSTRALIA
- XRCC1 and ERCC1 variants modify malignant mesothelioma risk: A case–control study
- (2011) M. Betti et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Trends in mesothelioma mortality rates in South Africa: 1995-2007
- (2011) D. Kielkowski et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Erionite exposure in North Dakota and Turkish villages with mesothelioma
- (2011) M. Carbone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Asbestos use and asbestos-related diseases in Asia: Past, present and future
- (2011) GIANG VINH LE et al. RESPIROLOGY
- Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma
- (2010) Ioannis Tourkantonis et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
- (2010) Kevin Hollevoet et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Diffusion-Weighted MRI of Malignant Pleural Mesothelioma: Preliminary Assessment of Apparent Diffusion Coefficient in Histologic Subtypes
- (2010) Ritu R. Gill et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications
- (2010) Ho Yun Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Endemic Malignant Mesothelioma: Exposure to Erionite Is More Important Than Genetic Factors
- (2010) Muzaffer Metintas et al. Archives of Environmental & Occupational Health
- Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos
- (2010) M. Gube et al. ARCHIVES OF TOXICOLOGY
- Occupation and cancer in Britain
- (2010) L Rushton et al. BRITISH JOURNAL OF CANCER
- Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases
- (2010) William G. Richards et al. CANCER
- Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma
- (2010) J. Creaney et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study
- (2010) Nikolaos Katirtzoglou et al. Clinical Lung Cancer
- Pleural Mesothelioma in New Caledonia: Associations with Environmental Risk Factors
- (2010) Francine Baumann et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study
- (2010) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
- (2010) Vanesa Gregorc et al. JOURNAL OF CLINICAL ONCOLOGY
- Vermiculite Worker Mortality: Estimated Effects of Occupational Exposure to Libby Amphibole
- (2010) Theodore C. Larson et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma
- (2010) Suresh S. Ramalingam et al. Journal of Thoracic Oncology
- A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307
- (2010) Sarita Dubey et al. Journal of Thoracic Oncology
- Non-occupational exposure to asbestos and malignant mesothelioma in the Italian National Registry of Mesotheliomas
- (2010) D. Mirabelli et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Surveillance of mesothelioma and workers' compensation in British Columbia, Canada
- (2010) T. L. Kirkham et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates
- (2010) S. Goldberg et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Potency Factors for Risk Assessment at Libby, Montana
- (2010) Suresh H. Moolgavkar et al. RISK ANALYSIS
- Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010
- (2010) N. M. Rahman et al. THORAX
- What is the best way to diagnose and stage malignant pleural mesothelioma?
- (2010) I. Zahid et al. Interactive Cardiovascular and Thoracic Surgery
- Endoscopic Ultrasound-Guided Fine Needle Aspiration for Staging of Malignant Pleural Mesothelioma
- (2009) David C. Rice et al. ANNALS OF THORACIC SURGERY
- Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy
- (2009) John M. Alvarez et al. ANZ JOURNAL OF SURGERY
- American College of Chest Physicians Consensus Statement on the Respiratory Health Effects of Asbestos
- (2009) Daniel E. Banks et al. CHEST
- Are Current or Future Mesothelioma Epidemics in Hong Kong the Tragic Legacy of Uncontrolled Use of Asbestos in the Past?
- (2009) Lap Ah Tse et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
- (2009) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005
- (2009) N. Le Stang et al. INTERNATIONAL JOURNAL OF CANCER
- Assessment of cancer risks due to environmental exposure to asbestos
- (2009) Hermen A L Driece et al. Journal of Exposure Science and Environmental Epidemiology
- Risk of Mesothelioma and Occupational Exposure to Asbestos and Man-Made Vitreous Fibers: Evidence From Two Case-Control Studies in Montreal, Canada
- (2009) Javier Pintos et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: A meta-analysis
- (2009) Ling Luo et al. RESPIRATORY MEDICINE
- Staging algorithm for diffuse malignant pleural mesothelioma☆
- (2009) Marcin Zieliński et al. Interactive Cardiovascular and Thoracic Surgery
- Soluble Mesothelin-related Protein in an Asbestos-exposed Population
- (2008) Eun-Kee Park et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Meta-Analysis of Asbestos-Related Cancer Risk That Addresses Fiber Size and Mineral Type
- (2008) D. Wayne Berman et al. CRITICAL REVIEWS IN TOXICOLOGY
- Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma
- (2008) Martin H. Chamberlain et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
- (2008) Martin F Muers et al. LANCET
- The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
- (2008) Justin Stebbing et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search